Targeting Hippo pathway: A novel strategy for Helicobacter pylori-induced gastric cancer treatment
Open Access
- 21 March 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 161, 114549
Abstract
No abstract availableKeywords
Funding Information
- Shandong First Medical University (2019QL024)
This publication has 153 references indexed in Scilit:
- Statins Are Associated With a Reduced Risk of Gastric Cancer: A Population-Based Case–Control StudyAmerican Journal of Gastroenterology, 2011
- Tao-1 Phosphorylates Hippo/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor PathwayDevelopmental Cell, 2011
- Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cellsProceedings of the National Academy of Sciences, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 LigaseJournal of Biological Chemistry, 2010
- LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodelingProceedings of the National Academy of Sciences, 2010
- Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradationOncogene, 2010
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCPGenes & Development, 2010
- Inflammation and Cancer: IL-6 and STAT3 Complete the LinkCancer Cell, 2009